FAQ - Bulk Billed MBS patient COVID-19 Vaccine Suitability Assessment Service

Information on the MBS COVID-19 Vaccine Suitability Assessment Service

Page last updated: 13 April 2022

PDF version FAQ-COVID-19 Vaccine Support Items including booster doses and co-administered vaccines - PDF 534 KB (PDF 468 KB)

Word version FAQ-COVID-19 Vaccines Support Items including booster doses and co-administered vaccines - Word 422 KB (Word 426 KB)

PDF version Medicare Support for COVID-19 Vaccinations – Scenarios - PDF 342 KB (PDF 340 KB)

Word version Medicare Support for COVID-19 Vaccination - Scenarios - Word 412 KB (Word 414 KB)

The Australian Government is committed to offering every person in Australia access to safe and effective COVID-19 vaccines at no cost.

This FAQ describes the 22 Medicare items that have been introduced to support the COVID-19 vaccine rollout. These items:

        Include vaccine suitability assessments, in-depth assessments, and a flag fall item for suitability assessments conducted outside consulting rooms, and a vaccine booster incentive payment.

        Are to be used for assessing the vaccine suitability for all doses and age cohorts in accordance with current clinical guidelines.

        Must be bulk billed. Bulk billing incentives cannot be claimed in association with the vaccine support items.

        Can only be accessed by General Practitioners (GPs) and Other Medical Practitioners (OMPs) working at or from a medical practice that is participating in the Governments’ COVID-19 vaccination roll-out. GPs or OMPs providing services to individuals at or from a practice that is not participating in the roll-out are not eligible to use the COVID-19 vaccine items or to provide COVID-19 vaccinations.

        Can only be used by GPs, OMPs and suitably qualified health professionals who are appropriately qualified and trained to provide an immunisation to the patient. This includes having completed any mandatory Commonwealth training associated with the delivery of COVID-19 vaccination services, as well as meeting any state or territory legislative requirements.

‘Medicare Support for COVID-19 Vaccinations – Scenarios’ includes a range of scenarios demonstrating the use of these items, including when it is appropriate to co-claim with a general attendance or other non-COVID-related item (e.g. for co-administration of influenza vaccines). The table below provides a summary of the combination of conditions in each scenario.





Scenario
Suitability assessment
In-depth assessment
Suitability assessments delivered on behalf of a GP/OMP
Flag Fall
PIP Incentive
Non-COVID related co-claim
Booster Incentive
Scenario 1
Scenario 2
Scenario 3
Scenario 4
(return visit)
Scenario 5
Scenario 6
Scenario 7
Scenario 8
Scenario 9
Scenario 10
Scenario 11
Scenario 12
Scenario 13
Scenario 14
Scenario 15
Scenario 16
Scenario 17
Scenario 18
Scenario 19
Scenario 20
Scenario 21
Scenario 22
Scenario 23
Scenario 24
Scenario 25







In this section